Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia

A 17-year-old girl was diagnosed with acute lymphoblastic leukemia (ALL). After the administration of high-dose methotrexate (MTX) or intrathecal MTX, the patient experienced transient hemiparesis and motor aphasia. Diffusion-weighted magnetic resonance imaging showed a high-intensity lesion in the bilateral centrum semiovale, and a vasospasm was detected in the proximal segment of bilateral A1 on magnetic resonance angiography. Edaravone was administered, and leucovorin rescue treatment was continued; eventually, the patient's neurological symptoms completely resolved. This finding suggested that vasospasm might be a mechanism underlying MTX-induced transient encephalopathy in adolescent and young adult patients with ALL.

[1]  H. Kantarjian,et al.  Acute lymphoblastic leukemia in adolescents and young adults , 2017, Cancer.

[2]  Hyun Ah Choi,et al.  Blood–brain barrier breakdown in reversible cerebral vasoconstriction syndrome: Implications for pathophysiology and diagnosis , 2017, Annals of neurology.

[3]  P. Saikrishnan,et al.  Methotrexate Induced Acute Encephalopathy-Occurrence on Re-challenge and Response to Aminophylline , 2014, Indian Journal of Hematology and Blood Transfusion.

[4]  T. Fuchigami,et al.  Posterior Reversible Encephalopathy Syndrome in Childhood: Report of Four Cases and Review of the Literature , 2012, Pediatric emergency care.

[5]  T. Sagar,et al.  Early CNS toxicity after intrathecal methotrexate , 2008, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion.

[6]  C. Bloomfield,et al.  What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. , 2008, Blood.

[7]  A. Baruchel,et al.  Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children , 2007, Leukemia.

[8]  A. Singhal.  Postpartum angiopathy with reversible posterior leukoencephalopathy. , 2004, Archives of neurology.

[9]  A. Lee,et al.  Transient encephalopathy following high-dose methotrexate. , 2003, Medical and pediatric oncology.

[10]  U. Jaehde,et al.  Biochemical and Clinical Aspects of Methotrexate Neurotoxicity , 2003, Chemotherapy.

[11]  S. J. James,et al.  DEXTROMETHORPHAN IS EFFECTIVE IN THE TREATMENT OF SUBACUTE METHOTREXATE NEUROTOXICITY , 2002, Pediatric hematology and oncology.

[12]  C. Pui,et al.  Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia , 1998, Leukemia.

[13]  M. Relling,et al.  Patient characteristics associated with high-risk methotrexate concentrations and toxicity. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Hirose,et al.  [Transient cerebral dysfunction induced by VCR, HD-MTX in a child with acute lymphocytic leukemia]. , 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[15]  N. Modiano.  Physical activity and asthma in children: a long way to go in China , 2011, World journal of pediatrics : WJP.

[16]  G. Rosen,et al.  Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. , 1980, Cancer treatment reports.